Is it possible to cut costs, increase efficiency, and improve quality—all at the same time? The GSK (GlaxoSmithKline) UAE division and their main logistics company GAC (Gulf Agency Company) exceeded their expectations when they implemented temperature monitoring solutions from TSS in outbound shipments from Dubai. Additionally, they reassured the safety of what's most valuable—the patient.

TSS, a leading Swedish Software-as-a-Service (SaaS) company specializing in automated temperature monitoring solutions, is thrilled to announce that it has been awarded the prestigious EcoVadis Silver Medal for its advanced sustainability performance. With an overall score of 65, TSS has secured its position among the top 13% of sustainable world-leading companies, firmly establishing itself as a trailblazer in the industry.

In an era where people can make instant cash transfers electronically from their phone and order physical goods to be delivered in hours to their location, there is a portion of the Clinical Supply Chain that seems mired in a staff intensive, manual, reactive business process. That process is evaluating temperature excursions for Clinical Trial material.

Where do the majority of your temperature excursions occur? Why not eliminate them?

We are glad to announce that we’re exhibiting at the next Clinical Trial Supply Europe conference organized by Arena International.

We’re glad to announce that we will participate in the Temperature Control and Logistics conference and exhibition for pharma supply chain professionals in Düsseldorf, Germany, on June 7th-8th.

Customer onboarding is one of the most important steps in making sure your customers are happy and confident in using your product. At TSS, we help companies in life sciences monitor complex temperature budgets with our advanced automated cloud software and temperature loggers. Making the onboarding process smooth is key to long-term customer satisfaction.

TSS, a leading provider of temperature-monitoring solutions for the life-science industry, proudly announces that it has retained the EcoVadis Silver Medal for the second consecutive year. This recognition is a testament to TSS’s ongoing commitment to sustainability, even as EcoVadis raised the bar for its assessment criteria in 2024.

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.

In the complex world of pharmaceuticals, sustainability is becoming a key part of business strategy. The push for a greener future is driven not only by government rules but also by the expectations of communities and customers. However, making the supply chain sustainable while balancing costs and maintaining high quality can be challenging. This requires careful planning and a commitment to long-term goals.

In the life-science industry, finding the right balance between cost and quality in the supply chain is crucial. This balance ensures that pharma companies remain financially healthy while delivering safe and effective products to patients. However, achieving this balance can be challenging due to the complexities of quality management, procurement, and temperature control.

World Telecommunication & Information Society Day (WTISD), celebrated annually on May 17th, highlights the pivotal role of digital technologies in fostering societal progress. This day serves as a reminder of the transformative power of innovation and digitalisation in building a sustainable future. At TSS, we are dedicated to leveraging advanced technologies to enhance the pharmaceutical supply chain while promoting sustainability.

Pharmaceutical companies are under pressure to bring new drugs to market quickly. This urgency is driven by the needs of patients, requirements from authorities, and investors. Clinical trials are a crucial part of this process, but they can be delayed by manual processes.

In the pharmaceutical industry, maintaining precise temperature control is paramount to ensuring product quality and compliance with regulatory standards. The integrity of pharmaceutical products is heavily reliant on storage conditions, with deviations in temperature potentially compromising their efficacy and safety.

Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.

The TSS User Forum is a platform for thought leadership and innovation in supply chain and temperature control technologies. This forum gathered industry experts from some of the most respected life science companies worldwide, covering topical realities such as automation benefits, data management, supply chain sustainability, and Direct-To-Patient.

Where do the majority of your temperature excursions occur? Why not eliminate them?

In an era where people can make instant cash transfers electronically from their phone and order physical goods to be delivered in hours to their location, there is a portion of the Clinical Supply Chain that seems mired in a staff intensive, manual, reactive business process. That process is evaluating temperature excursions for Clinical Trial material.

New technologies for tracking and temperature logging hold great potential, but which to choose? Get a copy of our latest white paper.

We are very excited to continue building an industry-leading team at TSS and so are delighted to officially welcome our new Chief Product Officer (CPO), Johanna Eriksson. Johanna has worked in the pharmaceutical industry for a number of years; she has lots of experience in collaborating with companies, agencies, and other stakeholders to create great products and solutions to make sure drugs are distributed safely for patients.

We are working with pharma and life sciences companies worldwide to drive improvements in their temperature monitoring and drug delivery processes. The foundation of our approach is to ensure the integrity of data and the safety of patients through implementing digital solutions into supply chains.

USB data loggers have been an important part of the life science temperature monitoring process for years. They have dramatically improved the safety of the drug distribution process by allowing the accurate measurement of temperature data at set points along the supply journey.

In Q4 of 2021, WBR Insights surveyed 100 Directors of Supply Chain Management and similar from pharma organizations across Europe and North America to find out about the challenges they face in 2021 and the innovative solutions they are putting in place.

Our North America VP Evan Hahn, recently presented a webinar where he outlined three different approaches for automating clinical supply chains.

The Future of Temperature Monitoring: How to lower the CO2 footprint with a Circular Supply Solution

Are you in pursuit of optimizing the temperature management of your clinical trials supply chain? Get inspired by experts from the field, and learn from their experiences.

Where do the majority of your temperature excursions occur? Why not eliminate them?

In light of the recent EMA and FDA guidelines, this session will discuss what role temperature monitoring may play in decentralized (DCT) and direct-to-patient (DTP) studies.

Where do the majority of your temperature excursions occur? Why not eliminate them?

We are excited to join the 20th Anniversary edition of Clinical Trial Supply East Coast on the 19th and 20th October 2022 in the Sheraton King of Prussia. The conference covers all things CTS from reducing timelines and streamlining processes to handling clinical supplies in a decentralized trial world. Along speakers from Pfizer, Merck, Janssen and many more we will present how digitalization of temperature processes can improve business outcomes in clinical trials.

New technologies for tracking and temperature logging hold great potential, but which to choose? Get a copy of our latest white paper.

Temperature management is critical when it comes to ensuring patient safety in clinical development, but we continue to use legacy point solutions that require heavy manual processes and duplication of data.